CLOAKINE
"CLOAKINE" is a word mark owned by Regeneron Pharmaceuticals, Inc., filed at the EUIPO on November 18, 2022. It is registered and covers class 42 (Computer and Scientific Services).
- Status
- Registered
- Since March 15, 2023
- Filed
- November 18, 2022
- Registered
- March 14, 2023
- Expires
- November 18, 2032
- Application no.
- 018797109
- Registration no.
- 018797109
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Word mark
- 1 class
Who owns CLOAKINE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Regeneron Pharmaceuticals, Inc.
Representative
Noerr Alicante IP, S.L.
Noerr Alicante IP, S.L
What the mark covers
The products and services CLOAKINE is filed for, grouped by Nice class.
Genetic engineering services, namely, the production of genetically-engineered antibodies for others
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2025/199 Section C.2.2
- Bulletin 2023/065 Section C.2.2
- Bulletin 2023/051 Section B.1
- Bulletin 2022/230 Section A.1
About CLOAKINE
Who owns the trademark "CLOAKINE"?
The EUIPO trademark "CLOAKINE" (application 018797109) is owned by Regeneron Pharmaceuticals, Inc.
What is the status of "CLOAKINE"?
Its status at the EUIPO is: registered.
When was "CLOAKINE" registered?
It was registered on March 14, 2023 and is due to expire on November 18, 2032.
Get this data via the API
Everything on this page comes from the Signa API. Pull CLOAKINE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d479e-c603-704b-b043-3d41083e30af
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d479e-c603-704b-b043-3d41083e30af",
"object": "trademark",
"mark_text": "CLOAKINE",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "018797109",
"filing_date": "2022-11-18",
"nice_classes": [
42
],
"owners": [
{
"name": "Regeneron Pharmaceuticals, Inc.",
"entity_id": "ent_019f7564-a0e8-7575-a3fd-12ec6e80fa07"
}
]
}